• Talabostat Mesylate (PT-100): Optimizing DPP4 Inhibition Wor

  2026-07-29

  Talabostat mesylate (PT-100) unlocks precise modulation of dipeptidyl peptidase activity, advancing both tumor microenvironment and inflammasome research. This guide details optimized experimental workflows, critical troubleshooting, and practical advantages when deploying this specific inhibitor of DPP4 and FAP in cellular and molecular assays.

• NADH in Research: Protocols, Workflows, and Troubleshooting

  2026-07-28

  NADH (reduced nicotinamide adenine dinucleotide) is at the heart of mitochondrial electron transport chain research and disease modeling, enabling precise redox manipulations and sensitive biomarker quantification. This guide demystifies advanced workflows, highlights experimental pitfalls, and translates the latest literature into actionable protocols—empowering researchers to maximize the impact of APExBIO’s rigorously characterized NADH.

• FH1 Small Molecule: Advancing Hepatocyte Maturation in iPS C

  2026-07-28

  Discover how FH1, a groundbreaking small molecule, transforms cultured hepatocyte function and iPS cell differentiation. This article offers a uniquely technical perspective, delving into assay optimization strategies and the latest optogenetic insights for liver cell research.

• Mifepristone (RU486): Mechanistic Leverage for Translational

  2026-07-27

  Explore how Mifepristone (RU486) is redefining progesterone receptor antagonism, bridging molecular precision with strategic translational research in oncology and reproductive biology. This article offers mechanistic depth, actionable protocol guidance, and competitive insight, and situates APExBIO’s high-purity formulation at the forefront of evolving cancer research, with perspectives on androgen receptor heterogeneity and beyond.

• A23187, Free Acid: Precise Calcium Ionophore for Cellular St

  2026-07-27

  A23187, free acid is a potent calcium ionophore that enables controlled elevation of intracellular Ca2+ for research applications. It facilitates apoptosis induction via mitochondrial permeability transition, phosphoinositide hydrolysis, and modulation of cell contractility. This article assembles atomic, verifiable facts on its mechanism, application boundaries, and optimal use parameters.

• Cardioprotective Mechanisms of Olive Oil Polyphenols: Focus

  2026-07-26

  This reference study rigorously compares high-phenolic and standard extra virgin olive oil (EVOO) extracts, isolating the effects of their key phenolic constituents—hydroxytyrosol and tyrosol—on antioxidant, anti-inflammatory, and anti-atherogenic pathways in macrophage models. The findings clarify how phenolic concentration modulates cellular responses relevant to cardiovascular health, providing mechanistic and quantitative data for oxidative stress and inflammation research.

• A-1155463: Unveiling Selective BCL-XL Inhibition for Cancer

  2026-07-25

  Explore the mechanisms and advanced research applications of BCL-XL inhibitor A-1155463 in apoptosis induction and overcoming drug resistance. This in-depth analysis offers unique protocol insights and highlights the translational relevance for both solid tumors and hematological malignancies.

• Bafilomycin A1 in Endosomal Escape and mRNA Delivery: New Ho

  2026-07-24

  Explore how Bafilomycin A1, a selective V-ATPase inhibitor, is shaping advanced mRNA delivery and endosomal escape strategies. This article uniquely bridges lysosomal research with emerging nanomedicine applications.

• SGI-1027 Induces Apoptosis in Huh7 Hepatocellular Carcinoma

  2026-07-24

  This study demonstrates that the DNA methyltransferase inhibitor SGI-1027 induces apoptosis in human Huh7 hepatocellular carcinoma cells through mitochondrial-mediated pathways, without affecting cell cycle distribution. The findings clarify SGI-1027’s mechanistic impact and inform its potential as a targeted epigenetic modulator for cancer research.

• Spleen-Targeted mRNA Vaccination Reprograms Immunity in HCC

  2026-07-23

  Lin et al. developed a spleen-targeted neoantigen mRNA vaccine (STNvac) for hepatocellular carcinoma, which drives potent antitumor responses by expanding a distinct ISG15+ CD8+ T cell population and promoting tertiary lymphoid structure formation. These findings illuminate new immune mechanisms and offer a blueprint for organ-targeted mRNA vaccine strategies in solid tumors.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Immun

  2026-07-23

  Accelerate your immunofluorescence and flow cytometry assays with the FITC Goat Anti-Rabbit IgG (H+L) Antibody, offering robust signal amplification and high specificity for rabbit IgG detection. Advanced troubleshooting and workflow optimization tips ensure reliable, reproducible results for demanding translational research applications.

• Light-Inducible RNA Switches for Precise Gene Therapy Contro

  2026-07-22

  This study presents a rationally engineered light-inducible RNA-releasing protein (LIRP) enabling reversible, spatiotemporal control of gene expression in vivo. The findings highlight LIRP's effectiveness for optogenetic regulation in gene and cell therapy, with particular relevance for diseases requiring on-demand, tissue-specific transgene activity.

• Propidium Iodide: Mechanistic Insight and Translational Impa

  2026-07-22

  This thought-leadership article unpacks the mechanistic, experimental, and strategic dimensions of propidium iodide (PI) application in translational research, bridging foundational cell biology with the demands of complex disease modeling and high-throughput screening. Highlighting new evidence from Toxoplasma gondii pathogenesis and recent protocol innovations, we chart a forward-looking path for PI-enabled discovery and validation.

• Tolazoline as an α2-Adrenergic Receptor Antagonist: Workflow

  2026-07-21

  Tolazoline, a dual-action α2-adrenergic receptor antagonist and ATP-sensitive K+ channel blocker, empowers researchers to dissect neuroendocrine and airway pathways in vitro and in vivo. This guide delivers stepwise protocols, troubleshooting strategies, and practical insights on leveraging Tolazoline from APExBIO for robust islet function and airway smooth muscle studies.

• Pomalidomide (CC-4047): Transforming Myeloma Model Selection

  2026-07-21

  Explore how Pomalidomide (CC-4047) is reshaping translational research in multiple myeloma. This thought-leadership piece synthesizes mechanistic insights, mutational landscape data, and hands-on protocol guidance to empower strategic experimental design. Drawing on recent exome-wide analyses and advanced model frameworks, we clarify how APExBIO’s Pomalidomide enables precision modulation of the tumor microenvironment, supports erythroid progenitor cell studies, and addresses emerging challenges in hematological malignancy research.

455 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page